Bio Green Med Solution (BGMS) Minority Interest (2022 - 2023)
Bio Green Med Solution (BGMS) posted quarterly Minority Interest of $3.4 million for Q2 2023, down 24.59% quarter-over-quarter from $4.5 million in Q1 2023.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Minority Interest (2022 - 2023) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Minority Interest for 2 consecutive years, with $3.4 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Minority Interest changed N/A year-over-year to $3.4 million; the TTM figure through Jun 2023 stood at $3.4 million (changed N/A YoY), while the FY2022 annual figure was $4.5 million, changed N/A from the prior year.
- Minority Interest declined to $3.4 million in Q2 2023 per BGMS's latest filing, from $4.5 million in the prior quarter.
- Across five years, Minority Interest topped out at $4.5 million in Q3 2022 and bottomed at $3.4 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.88 Bn | 133.03 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.94 Bn | 78.95 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn |
| 4 | Moderna | 57.34 Bn | 52.20 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.63 Bn | 44.63 Bn | - |
| 6 | BeOne Medicines | 40.44 Bn | 35.34 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.22 Bn | 27.38 Bn | - |
| 9 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.03 Mn | 1.24 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Sep 30, 2022 | 4.49 Mn |